Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Market Commentary

S&P 500 Retreats from Record High as Jobs Data Sparks Volatility

Robert Sasse by Robert Sasse
September 8, 2025
in Market Commentary, S&P 500, Trading & Momentum
0
S&P 500 Stock
0
SHARES
201
VIEWS
Share on FacebookShare on Twitter

The S&P 500 concluded Friday’s session in negative territory, relinquishing early gains that had propelled the benchmark index to a fresh all-time peak of 6,533 points. The index finished at 6,481.50, marking a daily decline of 20.58 points. This pullback represented a wave of profit-taking that emerged directly at the moment of the bulls’ greatest triumph.

Economic Data Pressures Fed Policy Outlook

Market volatility was primarily triggered by the latest US employment report, which revealed a weaker-than-anticipated labor market. The unemployment rate climbed to 4.3%, significantly exceeding forecasts. This development immediately fueled market speculation, with bets increasing for a potential 50-basis-point interest rate cut by the Federal Reserve at its September 17th meeting.

Bond markets reacted swiftly to the shifting expectations. The yield on the 10-year US Treasury note fell to 4.08%, its lowest level since April. Meanwhile, gold prices advanced to $3,639.80 per ounce, while oil held steady at $61.97 a barrel.

Mixed Performance Among Individual Stocks

Beneath the index’s movement, individual companies experienced dramatic swings. Broadcom surged by 9.4% following an exceptional quarterly report and the announcement of a $10 billion customer, widely believed to be OpenAI. Pool Corp. also posted gains, advancing 5.5% as investors bet on potential interest rate reductions.

However, the session brought substantial losses for others. Lululemon shares plummeted 18.6% after the company released disappointing sales figures and revised its guidance downward. Advanced Micro Devices (AMD) declined 6.6% following a analyst downgrade that cited concerns over waning demand for artificial intelligence products.

Should investors sell immediately? Or is it worth buying S&P 500?

Technical Perspective Remains Constructive

Despite the daily setback, the broader technical outlook for the S&P 500 remains decidedly bullish. The index continues to trade well above its key moving averages:
– 50-day moving average: 6,349.55 points
– 100-day moving average: 6,064.38 points
– 200-day moving average: 5,969.10 points

Technical analysts identify critical support at the 6,400-point level. A sustained hold above this threshold would keep upward prospects intact. The Relative Strength Index (RSI) reading of 58.3% indicates healthy momentum conditions without signaling overbought territory.

Institutional Flows Signal Underlying Confidence

Despite the pullback, institutional investment flows continued to demonstrate market confidence. The SPY ETF recorded substantial inflows of $4.4 billion, while the IVV ETF attracted $1.1 billion. Options traders exhibited more caution, however, with a put/call ratio of 1.15 indicating mild skepticism in the market.

The central question for traders is whether this retreat represents a healthy consolidation after a record-breaking run or the beginning of a more significant correction. The upcoming trading sessions around the 6,400-point marker are expected to provide crucial directional signals for the market’s near-term trajectory.

Ad

S&P 500 Stock: Buy or Sell?! New S&P 500 Analysis from February 7 delivers the answer:

The latest S&P 500 figures speak for themselves: Urgent action needed for S&P 500 investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

S&P 500: Buy or sell? Read more here...

Tags: S&P 500
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Communications Stock
Industrial

The Race to Rewire: Fiber Optics Reshape the Telecom Landscape

February 7, 2026
Hbt Financial Stock
Analysis

HBT Financial Stock Surges as Strategic Acquisition Nears Completion

February 7, 2026
Next Post
Airbnb Stock

Navigating Regulatory Headwinds: Airbnb's AI Ambitions Face Policy Challenges

Incyte Stock

Institutional Buying and Insider Selling: The Incyte Investment Conundrum

Mastercard Stock

Mastercard CFO Takes Center Stage at Key Investor Conference

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com